106 related articles for article (PubMed ID: 27723759)
1. Chromatin structure-based prediction of recurrent noncoding mutations in cancer.
Kim K; Jang K; Yang W; Choi EY; Park SM; Bae M; Kim YJ; Choi JK
Nat Genet; 2016 Nov; 48(11):1321-1326. PubMed ID: 27723759
[TBL] [Abstract][Full Text] [Related]
2. Predicting the recurrence of noncoding regulatory mutations in cancer.
Yang W; Bang H; Jang K; Sung MK; Choi JK
BMC Bioinformatics; 2016 Dec; 17(1):492. PubMed ID: 27912731
[TBL] [Abstract][Full Text] [Related]
3. The search for cis-regulatory driver mutations in cancer genomes.
Poulos RC; Sloane MA; Hesson LB; Wong JW
Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674
[TBL] [Abstract][Full Text] [Related]
4. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models.
Svetlichnyy D; Imrichova H; Fiers M; Kalender Atak Z; Aerts S
PLoS Comput Biol; 2015 Nov; 11(11):e1004590. PubMed ID: 26562774
[TBL] [Abstract][Full Text] [Related]
5. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Fujimoto A; Furuta M; Totoki Y; Tsunoda T; Kato M; Shiraishi Y; Tanaka H; Taniguchi H; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Wardell CP; Hayami S; Nakamura T; Aikata H; Arihiro K; Boroevich KA; Abe T; Nakano K; Maejima K; Sasaki-Oku A; Ohsawa A; Shibuya T; Nakamura H; Hama N; Hosoda F; Arai Y; Ohashi S; Urushidate T; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Ojima H; Hiraoka N; Okusaka T; Kubo M; Marubashi S; Yamada T; Hirano S; Yamamoto M; Ohdan H; Shimada K; Ishikawa O; Yamaue H; Chayama K; Miyano S; Aburatani H; Shibata T; Nakagawa H
Nat Genet; 2016 May; 48(5):500-9. PubMed ID: 27064257
[TBL] [Abstract][Full Text] [Related]
6. A Deep Learning Framework Identifies Pathogenic Noncoding Somatic Mutations from Personal Prostate Cancer Genomes.
Wang C; Li J
Cancer Res; 2020 Nov; 80(21):4644-4654. PubMed ID: 32907840
[TBL] [Abstract][Full Text] [Related]
7. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types.
Fredriksson NJ; Ny L; Nilsson JA; Larsson E
Nat Genet; 2014 Dec; 46(12):1258-63. PubMed ID: 25383969
[TBL] [Abstract][Full Text] [Related]
9. Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks.
Kalender Atak Z; Imrichova H; Svetlichnyy D; Hulselmans G; Christiaens V; Reumers J; Ceulemans H; Aerts S
Genome Med; 2017 Aug; 9(1):80. PubMed ID: 28854983
[TBL] [Abstract][Full Text] [Related]
10. Functional annotation of noncoding mutations in cancer.
Umer HM; Smolinska K; Komorowski J; Wadelius C
Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34282050
[TBL] [Abstract][Full Text] [Related]
11. Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers.
He B; Gao P; Ding YY; Chen CH; Chen G; Chen C; Kim H; Tasian SK; Hunger SP; Tan K
Sci Adv; 2020 Jul; 6(30):eaba3064. PubMed ID: 32832663
[TBL] [Abstract][Full Text] [Related]
12. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
[TBL] [Abstract][Full Text] [Related]
13. Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing.
Brinckmann A; Mischung C; Bässmann I; Kühnisch J; Schuelke M; Tinschert S; Nürnberg P
Electrophoresis; 2007 Dec; 28(23):4295-301. PubMed ID: 18041031
[TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Allory Y; Beukers W; Sagrera A; Flández M; Marqués M; Márquez M; van der Keur KA; Dyrskjot L; Lurkin I; Vermeij M; Carrato A; Lloreta J; Lorente JA; Carrillo-de Santa Pau E; Masius RG; Kogevinas M; Steyerberg EW; van Tilborg AA; Abas C; Orntoft TF; Zuiverloon TC; Malats N; Zwarthoff EC; Real FX
Eur Urol; 2014 Feb; 65(2):360-6. PubMed ID: 24018021
[TBL] [Abstract][Full Text] [Related]
15. Transposable Elements and DNA Methylation Create in Embryonic Stem Cells Human-Specific Regulatory Sequences Associated with Distal Enhancers and Noncoding RNAs.
Glinsky GV
Genome Biol Evol; 2015 May; 7(6):1432-54. PubMed ID: 25956794
[TBL] [Abstract][Full Text] [Related]
16. Highly selective isolation of unknown mutations in diverse DNA fragments: toward new multiplex screening in cancer.
Chakrabarti S; Price BD; Tetradis S; Fox EA; Zhang Y; Maulik G; Makrigiorgos GM
Cancer Res; 2000 Jul; 60(14):3732-7. PubMed ID: 10919642
[TBL] [Abstract][Full Text] [Related]
17. Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling.
Choi YJ; Rhee JK; Hur SY; Kim MS; Lee SH; Chung YJ; Kim TM; Lee SH
J Pathol; 2017 Jan; 241(1):57-66. PubMed ID: 27741368
[TBL] [Abstract][Full Text] [Related]
18. The Oncormed approach to genetic testing.
Carter CL; Scott JA; Glauber PM; Murphy PD
Genet Test; 1997; 1(2):137-44. PubMed ID: 10464638
[TBL] [Abstract][Full Text] [Related]
19. MUFFINN: cancer gene discovery via network analysis of somatic mutation data.
Cho A; Shim JE; Kim E; Supek F; Lehner B; Lee I
Genome Biol; 2016 Jun; 17(1):129. PubMed ID: 27333808
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of somatic noncoding mutation patterns in cancer.
Dietlein F; Wang AB; Fagre C; Tang A; Besselink NJM; Cuppen E; Li C; Sunyaev SR; Neal JT; Van Allen EM
Science; 2022 Apr; 376(6589):eabg5601. PubMed ID: 35389777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]